C. Michael Gibson, MD, an interventional cardiologist at the Beth Israel Deaconess Medical Center in Boston, spoke with Cardiovascular Business about several trials presented during the European Society of Cardiology (ESC) Congress regarding new anticoagulants, especially what these new drugs could mean for U.S. atrial fibrillation and acute coronary syndrome patients, if they are approved.
Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."
Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.
